Degron, CREATE, TenNor raise capital; Cabaletta posts CAR-T data

May 14, 2026 10:42 AM EDT News Briefing A Se­ries A, B and an IPO; Ca­balet­ta re­ports CAR-T re­sults ENDPOINTS 💸 A Se­ries A ex­ten­sion: US-Chi­na biotech De­gron Ther­a­peu­tics has col­lect­ed an ad­di­tion­al $40 mil­lion for its mol­e­c­u­lar glue de­grad­er plat­form … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER